摘要
目的:观察清化汤治疗急性盆腔炎的临床疗效。方法:将98例急性盆腔炎患者随机分为对照组与治疗组,对照组均采用常规西医治疗,治疗组在对照组基础上加用清化汤治疗,观察周期14 d。结果:治疗后两组白细胞介素1(Interleukin-1,IL-1)、肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)较治疗前均降低(P<0.05),白细胞介素2(Interleukin-2,IL-2)较治疗前均升高(P<0.05),超敏C-反应蛋白(high-sensitivity C-Reactive Protein,hs-CRP)、红细胞沉降率(Erythrocyte Sedimentation Rate,ESR)、白细胞(White Blood Cell,WBC)较治疗前均降低(P<0.01),下腹疼痛、发热、带下异常症状积分较治疗前均降低(P<0.05或P<0.01),治疗组改善程度均优于对照组(P<0.05);治疗组临床疗效总有效率高于对照组(P<0.05)。结论:清化汤治疗急性盆腔炎,能够抑制炎症因子表达,降低炎症反应程度,改善临床症状,提高临床疗效。
Objective: To observe the clinical efficacy of the Qinghua decoction (清化汤) on the acute pelvic inflammatory disease.Methods: 98 patients were randomly divided into the control group and treatment group. The control group was treated with conventional western medicine. The treatment group was treated with the Qinghua decoction more. Results: IL-1 and TNF-α were lower than those before treatment(P<0.05). IL-2 was higher than before treatment(P<0.05), and hs-CRP, ESR and WBC were lower than those before treatment(P<0.01), Lower abdominal pain, fever and abnormal symptoms were lower than before treatment in two groups(P<0.05 or P<0.01). And the improvement in the treatment group were better than the control group(P<0.05). The total effective rate in the treatment group was higher(P<0.05). Conclusion: The Qinghua decoction can inhibit the expression of inflammatory factors, reduce the degree of inflammatory reaction, improve clinical symptoms and clinical efficacy.
出处
《中医临床研究》
2019年第16期45-47,共3页
Clinical Journal Of Chinese Medicine
关键词
清化汤
急性盆腔炎
临床观察
The Qinghua decoction
Acute pelvic inflammatory disease
Clinical observation
